Stem Cell Clinic Publishes First Peer Reviewed Paper on Autism Stem Cell Therapy
SAN DIEGO--(BUSINESS WIRE)--The Institute for Cellular Medicine (www.cellmedicine.com) announced today what appears to be the first publication in a peer reviewed journal outlining scientific rationale for the use of stem cells in the treatment of autism.
“The application of stem cell therapy to autism, a condition affecting approximately 1 in 144 children, offers the possibility of addressing the root cause of this disorder,” said Dr. Gang Chen, one of the International Scientific Advisors for the Institute of Cellular Medicine. He continued, “While numerous clinics have used adult stem cells therapeutically for years, none of these clinics make it a priority to publish in the peer reviewed literature the scientific basis for their work and findings. As a result, anecdotal findings and observations which would have great value to academic researchers are largely ignored. We hope to correct this.”
The publication, entitled “Stem cell therapy for autism,” was published in the Journal of Translational Medicine and is freely available online at https://www.translational-medicine.com/content/pdf/1479-5876-5-30.pdf
“While embryonic stem cells are receiving the spotlight of the mass media, fears of carcinogenesis, immune rejection and lack of differentiation have blocked these cells from clinical use to date. In sharp contrast, adult stem cell therapy, which does not involve destruction of fetuses has demonstrated great success in various US and European clinical trials for conditions such as heart failure, liver cirrhosis, and Crohn’s disease. In fact, companies such as Osiris Therapeutics are already in Phase III FDA registration trials for their adult mesenchymal stem cell therapy product. By this publication, we hope to extend current clinical research of adult stem cells to autism,” concluded Dr. Chen.
About the Institute for Cellular Medicine
The Institute for Cellular Medicine is an international organization offering adult stem cell therapy for a variety of degenerative conditions ranging from multiple sclerosis, to rheumatoid arthritis, to heart failure. More information may be found at www.cellmedicine.com.
i'm independent medical researcher and biotechnologist , and mother of autistic girl .
My team is working towards discoverie about autism roots.
It looks like it is cell wall deficiency and ATM , CAMP energy production ( metabolizm ) , so only geno therapy is going to help .Stem cell is at the moment the only one way to correct this enviromentaly
activated genomic disease.
What in the world are you talking about? autism is not one but at least 15 different diseases....ATM cAMP??? please elaborate...this is a scientific forum here where I dont think they should allow people to write weird alternative medicine type products
next thing you know people will start promoting hyperbaric oxygen and fishoil on this site !!
What would be interesting is a discussion on the immunological alterations in subsets of autistic patients and the connection between the immune system and various stages of mental diseases. Various anti-depressants have immune modulatory effects, as well lithium is known to activate endogenous stem cells. The activator of endogenous stem cells that is discussed on StemCellPatents.com, valproic acid, the histone deacetylase inhibitor, that is used clinically for neurological conditions (anti-convulsant i think).
so the point i am trying to make is that if people really want to talk about autism on this site, they should first identify what in the world they are talking about and secondly, perhaps of more importance, the people should discuss specific scientific points about it.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.
Paula Stroll said...
There are numerous grants available for autism researchers. The problem is that there are no leads. We do not even have a concrete definition for what autism is yet !
The use of stem cells for regeneration of SPECIFIC DEFECTS is one thing, which I see is being done.